Orange Book product · Generic (ANDA)
ELTROMBOPAG OLAMINE
ELTROMBOPAG OLAMINE
At a glance
Apr 18, 2024
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 18, 2024
2 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
ELTROMBOPAG OLAMINE
Strength
EQ 12.5MG ACID/PACKET
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
AB
Application
ANDA 216620
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ELTROMBOPAG OLAMINE
- 2018PROMACTA KITBrand (NDA)
NDA 207027 · NOVARTIS
- 2011PROMACTABrand (NDA)
NDA 022291 · NOVARTIS
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 220660 · BIOCON PHARMA
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 220033 · HIKMA
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 219121 · DR REDDYS
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 212884 · AMNEAL
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 220250 · MSN
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 219638 · SOMERSET THERAPS LLC
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 216281 · ZYDUS PHARMS
- 2025ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 206788 · HETERO LABS LTD V
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
